FDA’s CBD Hearing Marathon Brings ‘Who’s-Who’ of Experts


Friday, May 31 marked a historic day for CBD, the starting point for a rulemaking on how the FDA will set rules to allow CBD in foods, pet supplements and cosmetics.   At the head table, various DC regulators listened to multiple experts during the morning session:

Amy Abernethy, MD, PhD Principal Deputy Commissioner, FDA — Chair

Douglas Throckmorton, MD Deputy Director, Regulatory Programs Center for Drug Evaluation and Research

Nick Alexander, JD Director, Intergovernmental Affairs Office of Policy, Legislation, and International Affairs, FDA

Dayle Cristinzio Director, Stakeholder Engagement Office of External Affairs, FDA

Jarilyn Dupont, JD Director of Regulatory Policy Office of Policy, FDA

Randall Gnatt, JD Regulatory Counsel Center for Veterinary Medicine, FDA

Rebecca Goldberg, JD Associate Chief Counsel Office of the Chief Counsel, FDA

Sharon Mayl, JD Senior Advisor for Policy Office of Foods and Veterinary Medicine, FDA

Erik Mettler, MPA, MPH Asst Commissioner, Partnerships and Policy Office of Regulatory Affairs FDA

Timothy Schell, PhD Director, Office of Surveillance and Compliance Center for Veterinary Medicine, FDA

Lowell Schiller, JD Principal Associate Commissioner for Policy Office of Policy, FDA

Sherene Sepehri, JD Associate Chief Counsel Office of the Chief Counsel,  FDA

Steven Tave, JD Director, Office of Dietary Supplement Programs, Center for Food Safety and Applied Nutrition, FDA

During the afternoon session, these key business and pharma witnesses testified.

Bill Grubb Noramco

Deb Kimless Pure Green

Douglas MacKay CV Sciences

Ray Mannion Zynerba Pharmaceuticals, Inc.

Rosemary Mazanet Columbia Care Inc.

Alice Mead Greenwich Biosciences (GW Pharma)

Stephen Mueller Mile High Labs

James Sharkey Therabis, LLC , and

Priyanka Sharma Kazmira LLC

Look for an in-depth report on the day’s events coming soon.

–Based in Denver, Dr. Lloyd Covens, DBA is a seasoned cannabis industry journalist and the publisher of West420 NewsWeekly. Writing his doctorate on diffusion of innovations, Covens has been an expert journalist/researcher for 20 years chronicling new technology, global television and renewable energy advancements. He has reported on developments in the cannabis and hemp industry with weekly reports since 2014 covering the western U.S. for legal medical cannabis, recreational sales and hemp production. Covens is also the creator of the annual CO Hemp CBD conference held in Pueblo, Colorado.

Never miss a story. Subscribe today.

Subscribe To Newsletter

By submitting this form, you are consenting to receive marketing emails from: AZ Cannabis News. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact